2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care (Endorsed by the American heart assocation, the cardiological society of India, and sociedad latino Americana de cardiologia intervencion; Affirmation of value by the canadian association of interventional cardiology-association canadienne de cardiologie d'intervention)

Charanjit S. Rihal, Srihari S. Naidu, Michael M. Givertz, Wilson Y. Szeto, James A. Burke, Navin K. Kapur, Morton Kern, Kirk N. Garratt, James A. Goldstein, Vivian Dimas, Thomas Tu

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Although historically the intra-aortic balloon pump has been the only mechanical circulatory support device available to clinicians, a number of new devices have become commercially available and have entered clinical practice. These include axial flow pumps, such as Impella®; left atrial to femoral artery bypass pumps, specifically the TandemHeart; and new devices for institution of extracorporeal membrane oxygenation. These devices differ significantly in their hemodynamic effects, insertion, monitoring, and clinical applicability. This document reviews the physiologic impact on the circulation of these devices and their use in specific clinical situations. These situations include patients undergoing high-risk percutaneous coronary intervention, those presenting with cardiogenic shock, and acute decompensated heart failure. Specialized uses for right-sided support and in pediatric populations are discussed and the clinical utility of mechanical circulatory support devices is reviewed, as are the American College of Cardiology/American Heart Association clinical practice guidelines.

Original languageEnglish (US)
Pages (from-to)E175-E196
JournalCatheterization and Cardiovascular Interventions
Volume85
Issue number7
DOIs
StatePublished - Jun 1 2015

Fingerprint

Cardiology
Hispanic Americans
India
Equipment and Supplies
Extracorporeal Membrane Oxygenation
Cardiogenic Shock
Percutaneous Coronary Intervention
Femoral Artery
Practice Guidelines
Heart Failure
Hemodynamics
Pediatrics
Population

Keywords

  • cardiogenic
  • percutaneous coronary intervention
  • shock
  • ventricular assist device

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

@article{49552bc9a0ea4e0b8640ea566e27e92e,
title = "2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care (Endorsed by the American heart assocation, the cardiological society of India, and sociedad latino Americana de cardiologia intervencion; Affirmation of value by the canadian association of interventional cardiology-association canadienne de cardiologie d'intervention)",
abstract = "Although historically the intra-aortic balloon pump has been the only mechanical circulatory support device available to clinicians, a number of new devices have become commercially available and have entered clinical practice. These include axial flow pumps, such as Impella{\circledR}; left atrial to femoral artery bypass pumps, specifically the TandemHeart; and new devices for institution of extracorporeal membrane oxygenation. These devices differ significantly in their hemodynamic effects, insertion, monitoring, and clinical applicability. This document reviews the physiologic impact on the circulation of these devices and their use in specific clinical situations. These situations include patients undergoing high-risk percutaneous coronary intervention, those presenting with cardiogenic shock, and acute decompensated heart failure. Specialized uses for right-sided support and in pediatric populations are discussed and the clinical utility of mechanical circulatory support devices is reviewed, as are the American College of Cardiology/American Heart Association clinical practice guidelines.",
keywords = "cardiogenic, percutaneous coronary intervention, shock, ventricular assist device",
author = "Rihal, {Charanjit S.} and Naidu, {Srihari S.} and Givertz, {Michael M.} and Szeto, {Wilson Y.} and Burke, {James A.} and Kapur, {Navin K.} and Morton Kern and Garratt, {Kirk N.} and Goldstein, {James A.} and Vivian Dimas and Thomas Tu",
year = "2015",
month = "6",
day = "1",
doi = "10.1002/ccd.25720",
language = "English (US)",
volume = "85",
pages = "E175--E196",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - 2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care (Endorsed by the American heart assocation, the cardiological society of India, and sociedad latino Americana de cardiologia intervencion; Affirmation of value by the canadian association of interventional cardiology-association canadienne de cardiologie d'intervention)

AU - Rihal, Charanjit S.

AU - Naidu, Srihari S.

AU - Givertz, Michael M.

AU - Szeto, Wilson Y.

AU - Burke, James A.

AU - Kapur, Navin K.

AU - Kern, Morton

AU - Garratt, Kirk N.

AU - Goldstein, James A.

AU - Dimas, Vivian

AU - Tu, Thomas

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Although historically the intra-aortic balloon pump has been the only mechanical circulatory support device available to clinicians, a number of new devices have become commercially available and have entered clinical practice. These include axial flow pumps, such as Impella®; left atrial to femoral artery bypass pumps, specifically the TandemHeart; and new devices for institution of extracorporeal membrane oxygenation. These devices differ significantly in their hemodynamic effects, insertion, monitoring, and clinical applicability. This document reviews the physiologic impact on the circulation of these devices and their use in specific clinical situations. These situations include patients undergoing high-risk percutaneous coronary intervention, those presenting with cardiogenic shock, and acute decompensated heart failure. Specialized uses for right-sided support and in pediatric populations are discussed and the clinical utility of mechanical circulatory support devices is reviewed, as are the American College of Cardiology/American Heart Association clinical practice guidelines.

AB - Although historically the intra-aortic balloon pump has been the only mechanical circulatory support device available to clinicians, a number of new devices have become commercially available and have entered clinical practice. These include axial flow pumps, such as Impella®; left atrial to femoral artery bypass pumps, specifically the TandemHeart; and new devices for institution of extracorporeal membrane oxygenation. These devices differ significantly in their hemodynamic effects, insertion, monitoring, and clinical applicability. This document reviews the physiologic impact on the circulation of these devices and their use in specific clinical situations. These situations include patients undergoing high-risk percutaneous coronary intervention, those presenting with cardiogenic shock, and acute decompensated heart failure. Specialized uses for right-sided support and in pediatric populations are discussed and the clinical utility of mechanical circulatory support devices is reviewed, as are the American College of Cardiology/American Heart Association clinical practice guidelines.

KW - cardiogenic

KW - percutaneous coronary intervention

KW - shock

KW - ventricular assist device

UR - http://www.scopus.com/inward/record.url?scp=84929711112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929711112&partnerID=8YFLogxK

U2 - 10.1002/ccd.25720

DO - 10.1002/ccd.25720

M3 - Article

VL - 85

SP - E175-E196

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 7

ER -